NCT01870687View on ClinicalTrials.gov

Efficacy and Safety of 20 mg (2 Tablets of 10mg)VAC BNO 1095 FCT on Cyclic Mastodynia and PMS

PHASE3TerminatedINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
Premenstrual SyndromeMastodynia
Interventions
DRUG

20mg VAC BNO 1095 FCT

DRUG

Placebo

Trial Locations (1)

80802

Private Doctor's office - Dr. Hannes Herold, Munich

Sponsors

Lead Sponsor

Bionorica SE
All Listed Sponsors
lead

Bionorica SE

INDUSTRY